Liver Diseases

(asked on 7th September 2016) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what the annual cost of care is for a person with (a) decompensated cirrhosis of the liver and (b) hepatocellular carcinoma.


Answered by
 Portrait
David Mowat
This question was answered on 12th September 2016

The information is not available in the format requested. Such information as is available is shown in the table below and is from reference costs, which are the average unit cost to National Health Service trusts and foundation trusts of providing defined services in a given financial year. Reference costs are published annually, with most recently available data being for 2014-15.

Reference costs for acute care are collected by healthcare resource group (HRG), which are standard groupings of clinically similar treatments that consume similar levels of healthcare resource. HRGs are organised by chapters and sub-chapters, representing different body systems, and HRG sub-chapters GC and PG describe hepatobiliary and pancreatic system disorders for adults and children respectively. The average costs in the following table will therefore include the costs to NHS hospitals of treating decompensated cirrhosis of the liver and hepatocellular carcinoma, as well as the costs of other related disorders.

These costs do not include high cost drugs, or treatment in outpatient or other settings outside of hospital. They reflect the costs of a single episode of care under one consultant for a patient admitted to hospital for either elective or non-elective treatment. Patients admitted to hospital may have multiple episodes of care and each one of these episodes will be recorded separately.

Total cost to NHS hospitals of treating hepatobiliary and pancreatic system disorders, 2014-15

Average cost per Finished Consultant Episode (£)

Malignant, Hepatobiliary or Pancreatic Disorders1

1,984

Non-Malignant, Hepatobiliary or Pancreatic Disorders2

1,751

Paediatric, Hepatobiliary or Pancreatic Disorders3

2,344

Source: Reference costs, Department of Health

Notes:

1. The following HRGs are included in the table:

GC12C Malignant, Hepatobiliary or Pancreatic Disorders, with Multiple Interventions

GC12D Malignant, Hepatobiliary or Pancreatic Disorders, with Single Intervention, with CC Score 5+

GC12E Malignant, Hepatobiliary or Pancreatic Disorders, with Single Intervention, with CC Score 2-4

GC12F Malignant, Hepatobiliary or Pancreatic Disorders, with Single Intervention, with CC Score 0-1

GC12G Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 6+

GC12H Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 3-5

GC12J Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 1-2

GC12K Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 0

2. GC17A Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Multiple Interventions, with CC Score 9+

GC17B Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Multiple Interventions, with CC Score 4-8

GC17C Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Multiple Interventions, with CC Score 0-3

GC17D Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Single Intervention, with CC Score 9+

GC17E Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Single Intervention, with CC Score 4-8

GC17F Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Single Intervention, with CC Score 0-3

GC17G Non-Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 8+

GC17H Non-Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 5-7

GC17J Non-Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 2-4

GC17K Non-Malignant, Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 0-1

3. PG71A Paediatric, Hepatobiliary or Pancreatic Disorders, with CC Score 2+

PG71B Paediatric, Hepatobiliary or Pancreatic Disorders, with CC Score 1

PG71C Paediatric, Hepatobiliary or Pancreatic Disorders, with CC Score 0

4. These HRGs are common groupings of the ICD-10 codes used to count the number of finished admission episodes with a primary or secondary diagnosis of hepatocellular carcinoma or decompensated cirrhosis. They also include other ICD-10 codes

5. For each HRG or other currency in the reference cost collection, NHS hospital trusts submit a unit cost and amount of activity undertaken.

Reticulating Splines